To further confirm that Cyclin D1 degradation induced by SHP2 loss occurred through the ubiquitin–proteasome pathway, we determined whether the deletion of SHP2 increased ubiquitinated Cyclin D1 in breast cancer cells. The gene discussed is CCND1; the disease is breast carcinoma.